BLOOMINGTON, Ind.--The largest study of patients with peripherally inserted central catheters (PICC) utilizing a subcutaneous anchoring securement system (SASS) ever conducted shows that using ...

Bluegrass Vascular picked up a CE mark for its central venous access catheter and is kicking off a limited commercial release for the device. The Surfacer Inside-Out Access Catheter System facilitates ...

The "Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition ...

Vascular Access Device Market · GlobeNewswire Inc. Dublin, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The "Vascular Access Device Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets ...

South San Francisco, CA - The FDA has approved tissue-type plasminogen activator (tPA) Cathflo? Activase ® (Alteplase) for the restoration of function to central venous access devices (CVADs), as ...

Registration now open: Beyond the vein, see central vascular access through the eyes of the patient Covalon presents a new webinar titled “Central Vascular Access Devices: Key Considerations from the ...

The global vascular access device (VAD) market is projected to grow steadily at a CAGR of ~6% during the forecast period. The key growth drivers include the rising prevalence of chronic diseases ...

Selbyville, Delaware, Nov. 04, 2020 (GLOBE NEWSWIRE) -- As per credible sources, worldwide vascular access devices market is expected to grow momentously and accumulate USD 7.72 billion by the year ...

Phase I and Pharmacologic Study of Oral ZD9331, A Novel Nonpolyglutamated Thymidylate Synthase Inhibitor, in Adult Patients With Solid Tumors PURPOSE: To determine whether cryopreserved solutions of ...

The peripheral vascular access device segment is expected to register the highest CAGR of 7.6% during the forecast period. The intravenous route of insertion segment is expected to register the ...